{"id":"W3031215633","doi":"10.1200/jco.2020.38.15_suppl.11505","title":"Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Nivolumab; Response Evaluation Criteria in Solid Tumors; Internal medicine; Progressive disease; Clinical endpoint; Oncology; Sarcoma; Neoadjuvant therapy; Cohort; Pathology; Cancer; Randomized controlled trial; Chemotherapy; Immunotherapy; Breast cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002018473,0.0002946428,0.003244547,0.000211309,0.00007999913,0.000008851398,0.0002475158,0.0003934576,0.00007429741],"category_scores_gemma":[0.005004955,0.0002021439,0.0006731447,0.000294652,0.0002456151,0.00007590398,0.000227295,0.0007280642,0.000001133865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006133513,"about_ca_system_score_gemma":0.0006938408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008229866,"about_ca_topic_score_gemma":0.00005423927,"domain_scores_codex":[0.9930354,0.0006817317,0.004919607,0.0004260046,0.0005839588,0.000353261],"domain_scores_gemma":[0.9903152,0.004220519,0.003531757,0.0003185433,0.0009200174,0.0006939896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4376007,0.2137024,0.2178089,0.0005767222,0.007752501,0.003933378,0.003471874,0.00002758356,0.01341777,0.00005552432,0.00348661,0.09816604],"study_design_scores_gemma":[0.1757862,0.4520607,0.3591805,0.0003725561,0.003343723,0.0003393884,0.0006855318,0.00168842,0.00449612,0.0001436604,0.001716947,0.000186197],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895232,0.001458583,0.00005479743,0.007246168,0.0002906403,0.00126464,0.00007565851,0.00001525146,0.00007108966],"genre_scores_gemma":[0.997496,0.0005701035,0.001204065,0.0002481882,0.0003599089,0.00002372365,0.00003276682,0.00003292394,0.00003230531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2618145,"threshold_uncertainty_score":0.8243189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1772293650814535,"score_gpt":0.444388128138905,"score_spread":0.2671587630574516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}